211 related articles for article (PubMed ID: 18339317)
1. Relationship between CD40 ligand expression and B type natriuretic peptide levels in patients with chronic heart failure.
Yan JC; Liu PJ; Du RZ; Liang Y; Ma GS; Zhu J; Luo D
Clin Chim Acta; 2008 Jun; 392(1-2):17-20. PubMed ID: 18339317
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung I; Choudhury A; Patel J; Lip GY
J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of CD40-CD40 ligand system in patients with essential hypertension.
Yan JC; Ma GS; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2005 May; 355(1-2):191-6. PubMed ID: 15820495
[TBL] [Abstract][Full Text] [Related]
4. Effects of alimentary lipemia and inflammation on platelet CD40-ligand.
Kälsch T; Elmas E; Nguyen XD; Kralev S; Leweling H; Klüter H; Dempfle CE; Borggrefe M
Thromb Res; 2007; 120(5):703-8. PubMed ID: 17289125
[TBL] [Abstract][Full Text] [Related]
5. Platelets contribute to enhanced MCP-1 levels in patients with chronic heart failure.
Stumpf C; Lehner C; Raaz D; Yilmaz A; Anger T; Daniel WG; Garlichs CD
Heart; 2008 Jan; 94(1):65-9. PubMed ID: 17575327
[TBL] [Abstract][Full Text] [Related]
6. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
7. Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome.
Yan JC; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Acta Pharmacol Sin; 2004 Feb; 25(2):251-6. PubMed ID: 14769218
[TBL] [Abstract][Full Text] [Related]
8. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
Song HM; Zhang J; Deng B; Luo M
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
[TBL] [Abstract][Full Text] [Related]
9. Relationship between upregulation of CD40 system and restenosis in patients after percutaneous coronary intervention.
Yan JC; Ding S; Liang Y; Ma GS; Zhu J; Feng Y; Luo D
Acta Pharmacol Sin; 2007 Mar; 28(3):339-43. PubMed ID: 17302995
[TBL] [Abstract][Full Text] [Related]
10. Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease.
Mason PJ; Chakrabarti S; Albers AA; Rex S; Vitseva O; Varghese S; Freedman JE
Am J Cardiol; 2005 Nov; 96(10):1365-9. PubMed ID: 16275179
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine modulates the CD40/CD40L system.
Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
[TBL] [Abstract][Full Text] [Related]
12. Platelet activation in acute, decompensated congestive heart failure.
Chung I; Choudhury A; Lip GY
Thromb Res; 2007; 120(5):709-13. PubMed ID: 17287016
[TBL] [Abstract][Full Text] [Related]
13. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD40 ligand in acute and chronic heart failure.
Ueland T; Aukrust P; Yndestad A; Otterdal K; Frøland SS; Dickstein K; Kjekshus J; Gullestad L; Damås JK
Eur Heart J; 2005 Jun; 26(11):1101-7. PubMed ID: 15716285
[TBL] [Abstract][Full Text] [Related]
15. Biologically active CD40 ligand is elevated in sickle cell anemia: potential role for platelet-mediated inflammation.
Lee SP; Ataga KI; Orringer EP; Phillips DR; Parise LV
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1626-31. PubMed ID: 16601237
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
Ludwiczek O; Kaser A; Tilg H
Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
[TBL] [Abstract][Full Text] [Related]
18. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
[TBL] [Abstract][Full Text] [Related]
19. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
[TBL] [Abstract][Full Text] [Related]
20. [Application value of combining brain natriuretic peptide, creatine phosphokinase and echocardiogram in the evaluation of polymyositis-related chronic heart failure].
Yin G; Mao L; Cen XM; Yang M; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):646-8, 660. PubMed ID: 22007490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
